SuperTarget goes quantitative: update on drug-target interactions

Nucleic Acids Res. 2012 Jan;40(Database issue):D1113-7. doi: 10.1093/nar/gkr912. Epub 2011 Nov 8.

Abstract

There are at least two good reasons for the on-going interest in drug-target interactions: first, drug-effects can only be fully understood by considering a complex network of interactions to multiple targets (so-called off-target effects) including metabolic and signaling pathways; second, it is crucial to consider drug-target-pathway relations for the identification of novel targets for drug development. To address this on-going need, we have developed a web-based data warehouse named SuperTarget, which integrates drug-related information associated with medical indications, adverse drug effects, drug metabolism, pathways and Gene Ontology (GO) terms for target proteins. At present, the updated database contains >6000 target proteins, which are annotated with >330,000 relations to 196,000 compounds (including approved drugs); the vast majority of interactions include binding affinities and pointers to the respective literature sources. The user interface provides tools for drug screening and target similarity inclusion. A query interface enables the user to pose complex queries, for example, to find drugs that target a certain pathway, interacting drugs that are metabolized by the same cytochrome P450 or drugs that target proteins within a certain affinity range. SuperTarget is available at http://bioinformatics.charite.de/supertarget.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Databases, Factual*
  • Drug Discovery*
  • Metabolic Networks and Pathways / drug effects
  • Pharmaceutical Preparations / chemistry
  • Proteins / chemistry
  • Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
  • Signal Transduction / drug effects

Substances

  • Pharmaceutical Preparations
  • Proteins
  • Receptors, Vascular Endothelial Growth Factor